The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IGF-Child-Turcotte-Pugh score as a predictor of treatment outcome in Child-Pugh A, advanced hepatocellular carcinoma patients undergoing sorafenib therapy.
 
Yehia I. Mohamed
No Relationships to Disclose
 
Aliya Qayyum
No Relationships to Disclose
 
Manal Hassan
No Relationships to Disclose
 
Lianchun Xiao
No Relationships to Disclose
 
Dan G. Duda
No Relationships to Disclose
 
Rikita Hatia
No Relationships to Disclose
 
Sunyoung S. Lee
No Relationships to Disclose
 
Robert A. Wolff
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
Jeffrey Morris
No Relationships to Disclose
 
Lina Altameemi
No Relationships to Disclose
 
James C. Yao
No Relationships to Disclose
 
Hesham M. Amin
No Relationships to Disclose
 
Ahmed Omar Kaseb
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Bayer Health; Bristol-Myers Squibb; Exelixis; Merck
Consulting or Advisory Role - Bayer Health; Bristol-Myers Squibb; Exelixis; Merck
Research Funding - Adaptimmune (Inst); Bayer/Onyx (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Hengrui Pharmaceutical (Inst); Hengrui Pharmaceutical (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Bristol-Myers Squibb; Exelixis; Merck